Letter Article

MicroRNA Expression Profile Separates Squamous Cell Carcinoma by Mode of Differentiation

Author(s): Andani Marumo, Adam Botha, Julitha Molepo, Henry Adeola, Pumza Magangane* and Mulalo Molaudzi

Volume 12, Issue 2, 2023

Published on: 05 May, 2023

Page: [87 - 91] Pages: 5

DOI: 10.2174/2211536612666230418103004

Price: $65


Background: Squamous cell carcinoma (SCC) is a non-melanoma skin cancer with several risk factors including age and sun exposure. The degree of histological differentiation is considered an independent predictor of recurrence, metastasis, and survival. MicroRNAs (miRNAs) are small non-coding RNAs that play an important role in regulating gene expression, culminating in the initiation and progression of multiple tumors. The aim of this study was to determine changes in miRNA expression as a result of the mode of differentiation in SCC.

Methods: We analyzed 29 SCC samples that were separated by mode of differentiation into well (n=4), moderate (n=20) and poor (n=5). Of the 29 samples, five had matched normal tissues, which were used as controls. Total RNA was extracted using the RNeasy FFPE kit, and miRNAs were quantified using Qiagen MiRCURY LNA miRNA PCR Assays. Ten miRNAs (hsa-miR-21, hsa-miR-146b-3p, hsa-miR-155-5p, hsa-miR-451a, hsa-miR-196-5p, hsa-miR-221-5p, hsa-miR-375, hsa-miR-205-5p, hsa-let-7d-5p and hsa-miR-491-5p) that have been previously differentiated in cancer, were quantified. A fold regulation above 1 indicated upregulation and below 1, downregulation.

Results: Hierarchical clustering showed that the miRNA expression profile in the moderately differentiated group was similar to the well-differentiated group. The miRNA with the greatest upregulation in the moderate group was hsa-miR-375, while in the well group, hsa-miR-491-5p showed the greatest downregulation.

Conclusion: In conclusion, this study observed that the well and moderate groups had similar microRNA expression patterns compared to the poorly differentiated group. MicroRNA expression profiling may be used to better understand the factors underpinning mode of differentiation in SCC.

Keywords: Squamous cell carcinoma (SCC), MiRNA, Microarray, RNA, keratin, tumor cells.

Graphical Abstract
Jögi A, Vaapil M, Johansson M, Påhlman S. Cancer cell differentiation heterogeneity and aggressive behavior in solid tumors. Ups J Med Sci 2012; 117(2): 217-24.
[http://dx.doi.org/10.3109/03009734.2012.659294] [PMID: 22376239]
Padma R, Kalaivani A, Sundaresan S, Sathish P. The relationship between histological differentiation and disease recurrence of primary oral squamous cell carcinoma. J Oral Maxillofac Pathol 2017; 21(3): 461.
[http://dx.doi.org/10.4103/jomfp.JOMFP_241_16] [PMID: 29391735]
Yan W, Wistuba II, Emmert-Buck MR, Erickson HS. Squamous cell carcinoma – similarities and differences among anatomical sites. Am J Cancer Res 2011; 1(3): 275-300.
[PMID: 21938273]
Dotto GP, Rustgi AK. Squamous cell cancers: A unified perspective on biology and genetics. Cancer Cell 2016; 29(5): 622-37.
[http://dx.doi.org/10.1016/j.ccell.2016.04.004] [PMID: 27165741]
Stratigos A, Garbe C, Lebbe C, et al. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline. Eur J Cancer 2015; 51(14): 1989-2007.
[http://dx.doi.org/10.1016/j.ejca.2015.06.110] [PMID: 26219687]
Guo H, Ingolia NT, Weissman JS, Bartel DP. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010; 466(7308): 835-40.
[http://dx.doi.org/10.1038/nature09267] [PMID: 20703300]
Zhang L, Huang J, Yang N, et al. microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci 2006; 103(24): 9136-41.
[http://dx.doi.org/10.1073/pnas.0508889103] [PMID: 16754881]
Ferreira I, Boff AL, Luzzatto L, Martins Souza PR, Bevilaqua M. Well-differentiated squamous cell carcinoma: Is histological differentiation a relevant prognostic parameter? Dermatol Pract Concept 2021; 11(2): e2021034.
[http://dx.doi.org/10.5826/dpc.1102a34] [PMID: 33954017]
Ren J, Jin P, Wang E, Marincola FM, Stroncek DF. MicroRNA and gene expression patterns in the differentiation of human embryonic stem cells. J Transl Med 2009; 7(1): 20.
[http://dx.doi.org/10.1186/1479-5876-7-20] [PMID: 19309508]
Yao S, Xu J, Zhao K, et al. Down-regulation of HPGD by miR-146b-3p promotes cervical cancer cell proliferation, migration and anchorage-independent growth through activation of STAT3 and AKT pathways. Cell Death Dis 2018; 9(11): 1055.
[http://dx.doi.org/10.1038/s41419-018-1059-y] [PMID: 30333561]
Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435(7043): 834-8.
[http://dx.doi.org/10.1038/nature03702] [PMID: 15944708]
Zhang B, Li Y, Hou D, Shi Q, Yang S, Li Q. MicroRNA-375 inhibits growth and enhances radiosensitivity in oral squamous cell carcinoma by targeting insulin like growth factor 1 receptor. Cell Physiol Biochem 2017; 42(5): 2105-17.
[http://dx.doi.org/10.1159/000479913] [PMID: 28810236]
Cao B, Ji T, Zhou B, Zou J, Jiao GQ. Predicting the target genes of microRNA based on microarray data. Genet Mol Res 2013; 12(4): 6059-66.
[http://dx.doi.org/10.4238/2013.December.2.4] [PMID: 24338400]
Bai H, Wu S. miR-451: A novel biomarker and potential therapeutic target for cancer. OncoTargets Ther 2019; 12: 11069-82.
[http://dx.doi.org/10.2147/OTT.S230963] [PMID: 31908476]
Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 2009; 10(10): 704-14.
[http://dx.doi.org/10.1038/nrg2634] [PMID: 19763153]
Rock AN, Fisher MD, Amborski G, et al. MicroRNA expression profiling of cutaneous squamous cell carcinomas arising in different sites. Otolaryngol Head Neck Surg 2020; 163(3): 538-45.
[http://dx.doi.org/10.1177/0194599820918855] [PMID: 32423289]
Lopes CB, Magalhães LL, Teófilo CR, et al. Differential expression of hsa-miR-221, hsa-miR-21, hsa-miR-135b, and hsa-miR-29c suggests a field effect in oral cancer. BMC Cancer 2018; 18(1): 721.
[http://dx.doi.org/10.1186/s12885-018-4631-z] [PMID: 29976158]
Gong ZH, Zhou F, Shi C, et al. miRNA-221 promotes cutaneous squamous cell carcinoma progression by targeting PTEN. Cell Mol Biol Lett 2019; 24(1): 9.
[http://dx.doi.org/10.1186/s11658-018-0131-z] [PMID: 30891072]
Lazar AD, Dinescu S, Costache M. Deciphering the molecular landscape of cutaneous squamous cell carcinoma for better diagnosis and treatment. J Clin Med 2020; 9(7): 2228.
[http://dx.doi.org/10.3390/jcm9072228] [PMID: 32674318]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy